Status:
COMPLETED
The Feasibility of Pertussis Immunization in a Canadian Emergency Department
Lead Sponsor:
University of Prince Edward Island
Collaborating Sponsors:
The Queen Elizabeth Hospital
Conditions:
Pertussis
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Randomized controlled trial of 2 strategies to provide adults with the Tdap vaccine to patients presenting to the emergency department. Rates of vaccination as well as effects on department efficiency...
Detailed Description
This study is a prospective randomized, controlled trial of two strategies to provide patients with the pertussis vaccine. Eligible adult patients with be offered pertussis vaccination in the Emergenc...
Eligibility Criteria
Inclusion
- Adults age 18 and above
- Have not received Tdap vaccine as an adult (age 18 and above) or have not received Tdap vaccine within 10 years, or unsure of vaccination status
Exclusion
- Acute significant illness (Canadian Triage and Acuity Scale = 1)
- Deemed "in too much distress" by triage nurse
- Acute Febrile illness
- Allergy to vaccine or vaccine components
- Pts presenting for wound care (are normally given the vaccine as part of wound care)
- Pregnancy \< 26 weeks
Key Trial Info
Start Date :
July 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2017
Estimated Enrollment :
644 Patients enrolled
Trial Details
Trial ID
NCT03304275
Start Date
July 10 2017
End Date
December 20 2017
Last Update
January 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Elizabeth Hospital
Charlottetown, Prince Edward Island, Canada, PO Box 6600